Bone mineral density in human immunodeficiency virus-1 infected men with hypogonadism prior to highly-active-antiretroviral-therapy (HAART)

European Journal of Medical Research

Volumn 14, Issue 2, 2009, Pages 59-64

  Teichmann, Joachim ^a,b,c   Lange, U ^b   Discher, T ^b   Lohmeyer, J ^b   Stracke, H ^b   Bretzel, R G ^b  

^a Medical Clinic C   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c StJosefs Krankenhaus Heidelberg   (Germany)

Author keywords

Bone Mineral Density; Calciotropic Hormones; HIV; Hypogonadism

Indexed keywords

ANTIRETROVIRUS AGENT; OSTEOCALCIN;

ADULT; ARTICLE; BONE DENSITY; BONE METABOLISM; CONTROLLED STUDY; CROSS LINKING; CROSS-SECTIONAL STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; ENDOCRINE FUNCTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HORMONE BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOGONADISM; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; OSSIFICATION; OSTEOLYSIS; OSTEOPENIA; TESTIS FUNCTION; URINALYSIS; URINARY EXCRETION; WASTING SYNDROME;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BONE DENSITY; BONE DISEASES, METABOLIC; HIV INFECTIONS; HIV-1; HUMANS; HYPOGONADISM; MALE; MIDDLE AGED; OSTEOCALCIN; PARATHYROID HORMONE; PREVALENCE; TESTOSTERONE; YOUNG ADULT;

EID: 61849182433     PISSN: 09492321     EISSN: None     Source Type: Journal    
DOI: 10.1186/2047-783x-14-2-59     Document Type: Article

References (39)

1. Zaloga GP, and Chernow B: The multifactorial basis for hypocalcemia during sepsis studies of parathyroid hormone-vitamine D axis. Ann Int Med 1987; 107: 36-41.
2. Kuehn EW, Anders HJ, Bogner JR, Obermaier J, Goebel FD, Schlöndorff D: Hypocalcaemia in HIV-infection and AIDS. J Intern Med 1999; 245: 69-73.
3. Dluhy RG: The growing spectrum of HIV-releated endocrine abnormalities J Clin Endocrinol Metab 1990; 70: 563-565.
4. Glass AR, and Eil C: Ketoconazole-induced reduction in serum 1,25-dihydroxy-vitamin D, total serum calcium in hypercalcemic patients. J Clin Endocrinol Metab 1988; 66: 934-938.
5. Jacobs MB: The aquired immune deficiency syndrome and hypercalcemia. West J Med 1986; 114: 467-471.
6. Pont A: Unusual causes of hypercalcemia. Endocrinol Metabol Clin North Am 1989; 18: 753-764.
7. Hernandez Quero J, Centeno NO, Munoz-Torres M, Martinez-Perez A, and Higuera Torres-Puchol J M: Alterations in bone turnover in HIV-positive patients Infection; 1993, 21: 220-222.
8. Serrano M, Marinoso JC, Soriano JC, Rubies-Prat J, Aubia J. Coll, J., Bosch J, Del Rio I, Vila J, Goday A, and Nacher M: Bone remodeling in human immunodeficiency virus-1-1 infected patients. A histomorphometric Study. Bone 1995; 16: 185-191.
9. Teichmann J, Stephan E, Discher T, Lange U, Federlin K, Stracke H, Friese G, Lohmeyer J, Bretzel RG: Changes in calciotropic hormones and biochemical markers of bone metabolism in patients with human immunodeficiency virus infection. Metabolism 2000; 49: 1134-1139.
10. Pathon NIJ, Macallan DC, Griffin GE, Pazianas M: Bone mineral density in patients with human immunodeficiency virus infection. Calcif Tissue Int 1997; 61: 30-32.
11. Tebas P, Powderly WG, Claxton S, Marin D, Tantisriwat T, Teitelbaum SL, Yarasheski KE: Accelerated bone and mineral loss in HIV-infected patients receiving potent antiretroviral therapy. AIDS; 2000, 14: 63-67.
12. Carr A, Miller J, Eisman JA, Cooper DA: Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy. AIDS 2001; 15: 703-709.
13. Moore AL, Vashisht A, Sabin CA, Mocroft A, Madge S, Phillips AN, Studd JW, Johnson MA. Reduced bone mineral density in HIV-positive individuals AIDS 2001; 15: 1731-1733.
14. Manalogas SC, Jilka RL, Bone marrow, cytokines, and bone remodelling. Emerging insights into pathophysiology of osteoporosis. N Engl J Med 1995; 332: 529-534.
15. Orwoll ES, Klein RF. Osteoporosis in men Endocrin Rev 1995; 16: 87-116
16. Horowitz MC Cytokines and estrogen in bone: Antiosteoporotic effects. Science 1993; 260: 626-627.
17. Dobbs AS, Demsey MA, Ladenson PW, Polk BF, Endocrine disorders in men infected with human immunodeficiency virus Am J Med 1988; 84: 611-616.
18. Youle MS: Severe hypocalcemia in AIDS patients treated with foscarnet and pentamidine. Lancet 1988; 331: 1455-1456.
19. Jacobson MA, Gambertoglio JG, Aweeka FT, Causey DM, Portale AA: Foscarnet-induced hypocalcemia and effects of foscarnet on calcium metabolism. J Clin Endocrinol Metab 1991; 72: 1130-1135.
20. Bühl A, and Zöfel P. SPSS für Windows Version 6. Addison-Wesley; 1994.
21. Fairfield WP, Finkelstein JS, Klibanski A, Grinspon SK. Osteopenia in eugonadal men with acquired immunodeficiency syndrome wasting syndrome. J Clin Endocrinol Metab 2001; 86: 2020-2026.
22. Mulligan K, Zackin R, Von Roenn JH, Chesney MA, Egorin MJ, Sattler FR, Benson CA, Liu T, Umbleja T, Shriver S, Auchus RJ, Schambelan M: Testosterone supplementation of megestrol therapy does not enhance lean tissue accrual in men with human immunodeficiency virus-associated weight loss: a randomized, double-blind, placebo-controlled, multicenter trial. J Clin Endocrinol Metab 2007; 92: 563-70.
23. Rietschel P, Corcoran C, Stanlay T, Basgoz N, Klibanski A, Grinspoon SK. Prevalence of hypogonadism among men with weight loss related to human immunodeficiency virus infection who were received highly active antiretroviral therapy. Clin Infect Dis 2000; 31: 1240-1244.
24. Mylonakis E, Koutkia P, Grinspoon SK. Diagnosis and treatment of androgen-deficiency in human immunodeficiency virus-infected men and women. Clin Infect Dis 2001; 15: 857-864.
25. Huang JS, Wilkie SJ, Sullivan MP, Grinspoon S: Reduced bone density in androgen-deficient women with acquired immune deficiency syndrome wasting. J Endocrinol Metab 2001; 86: 3533-3539.
26. McNurlan MA, Garlick PJ, Frost RA, Decristofaro KA, Lang CH, Steigbigel RT, Fuhrer J, Gelato M: Albumin synthesis and bone kollagen formation in human immunodeficiency virus-positive subjects. Differential effects of growth hormone administration. J Clin Endocrinol Metab 1999; 83: 3050-3055.
27. Aukrust P, Haug Cj, Ueland T, Lien E, Müller F, Espevik T, Bollerslev J, Froland SS: Decreased bone formative and enhanced resorptive markers in human immunodeficiency virus infection: Inivation of normalization of the bone-remodeling process during highly active antiretroviral therapy. J Clin Endocrinol Metab 1999; 84: 145-150.
28. Aukrust P, Liabakk NB, Müller F, Lien E, Espevik T, Froland SS: Serum levels of tumor necrosis factor (TNFα) and soluble TNF receptors in human immunodeficiency virus type 1-infection -correlations to clinical, immunologic, and virologic parameters. J Infect Dis 1994; 169: 420-424.
29. Hofbauer LC, Khosla S, Dunstan CR, Lacey DL, Boyle WJ, Riggs BL: The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res 2000; 15: 2-12.
30. Haug C, Müller F, Aukrust P et al: Subnormal serum concentration of 1,25-vitamin D in human immunodeficiency virus infection: Correlation with the degree of immunodeficiency and survival. J Infect Dis 1994; 169: 889-893.
31. Jaeger Ph, Otto St, Speck RF, Villiger L, Horber FF, Casez JP, and Takkinen R. Altered parathyroid gland function in severely immunocompromised patients infected with human immunodeficiency virus. J Clin Endocrinol Metab 1994; 79: 1701-1705.
32. Pedrazzoni Vescovi PP, Maninetti L, Michelini M, Zaniboni G, Pioli G, Costi D, Alfano FS, and Passeri M. Effects of chronic heroin abuse on bone and mineral metabolism. Acta endocrinol 1993; 93: 42-44.
33. Nolan D, Upton R, McKinnon E, John M, James I, Adler B, Roff G, Vasikaran S, Mallal S: Stable or increasing bone mineral density in HIV-infected patients treated with nelfinavir or indinavir. AIDS 2001; 15: 1275-1280.
34. Klein R, Lo Y, Santoro N, Dobs A: Androgen levels in older men who have or who are at risk of acquiring HIV infection. Clin Infect Dis 2005; 41: 57-66.
35. Crum-Cianflone NF, Bavaro M, Hale B,. Amling C, Truett A, Brandt C, Pope B, Furtek K, Medina S, Wallace MR: Erectile dysfunction and hypogonadism among men with HIV. AIDS Patient Care STDS 2007; 21: 9-19.
36. Mondy K, Yarashekski K, Powderly WG, Whyte M, Claxton S, DeMarco D, Hoffmann M, Tebas P: Longitudinal evaluation of bone mineral density and bone markers in human imunodeficiency virus infected individuals. Clin Infect Dis 2003; 36: 482-490.
37. Bhasin S, Cunningham GR, Haves FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, Montori VM: Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2006; 91: 1995-2010.
38. Grinspoon S: Androgen deficiency and HIV Infection. Clinical Infect Diseases 2005; 41: 1804-5.
39. Clay PG, Voss LE, Williams C, Daume EC: Valid treatment options for osteoporosis and osteopenia in HIV-infected persons. Ann Pharmacotherap 2008; 42: 670-9.